Why the study?
Decremental evoked potential (DEEP) is mainly used for ventricular arrhythmias, and this study investigated the characteristics and clinical significance of atrial functional substrates expressed by DEEP in AF.
Does atrial decremental evoked potential (DEEP) correlate with clinical characteristics and outcomes in patients undergoing atrial fibrillation ablation?
Does atrial decremental evoked potential (DEEP) correlate with clinical characteristics and outcomes in patients undergoing atrial fibrillation ablation?
Atrial decremental evoked potential (DEEP) mapping identifies functional substrates that correlate with AF duration, structural remodeling, and early recurrence after ablation.
May support risk stratification after AF ablation; leaves open whether DEEP mapping improves outcomes in prospective trials.
Background: Decremental evoked potential (DEEP) is one of the functional substrates mainly used in the field of ventricular arrhythmias, which is suggested to be a critical target of reentrant ventricular tachycardia. Objective: The purpose of this study is to investigate the characteristics of patients with atrial functional substrates expressed by DEEP and their clinical significance. Methods: Patients presenting for atrial fibrillation (AF) ablation from April 2023 to March 2024 at Tottori University Hospital were analyzed. After cryoballoon pulmonary vein isolation, DEEP was evaluated at the left atrial roof and posterior wall by extrastimulus pacing maneuvers. To verify the clinical significance of atrial DEEP, the relationship between atrial DEEP and various clinical valuables including the pericardial fat volume and clinical outcomes was assessed. Results: .001). Conclusion: This study demonstrated a correlation between atrial DEEP and longer duration of AF, higher brain natriuretic peptide levels, greater pericardial fat volume, and more early AF recurrence, suggesting that DEEP reflects a certain aspect of atrial electrophysiological remodeling and is a potential ablation target for AF.
No takes yet. Share an insight, caveat, or question.
Kotake et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: